Correction: SGLT2 inhibitors and their role in reducing adiposopathy and inflammation in diabetes and non-diabetes CKD patients

International Urology and Nephrology 2026 Open access

Read full text

Authors: Ana Checa-Ros, Owahabanun-Joshua Okojie, Nelia Steib, Antonio Bellasi, Pilar Salvador, Fortea Isabel, Luis D’Marco

DOI: 10.1007/s11255-026-05028-0

Cited by: 0

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Diabetes Treatment and Management Adipokines Inflammation and Metabolic Diseases